These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 18540870)

  • 1. Prediction of attack frequency in migraine treatment.
    Maas HJ; Snelder N; Danhof M; Della Pasqua O
    Cephalalgia; 2008 Aug; 28(8):847-55. PubMed ID: 18540870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of headache response in migraine treatment.
    Maas HJ; Danhof M; Della Pasqua OE
    Cephalalgia; 2006 Apr; 26(4):416-22. PubMed ID: 16556242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fixed-dose sumatriptan and naproxen in poor responders to triptans with a short half-life.
    Mathew NT; Landy S; Stark S; Tietjen GE; Derosier FJ; White J; Lener SE; Bukenya D
    Headache; 2009 Jul; 49(7):971-82. PubMed ID: 19486178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment and prophylaxis of an acute migraine attack].
    Diener HC; Gendolla A
    MMW Fortschr Med; 2004 Sep; 146(35-36):41, 43-5. PubMed ID: 15540539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Applying the benefits of the AwM study in the clinic.
    Dodick DW
    Cephalalgia; 2008 Sep; 28 Suppl 2():42-9. PubMed ID: 18715332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Headache classification by history has only limited predictive value for headache episodes treated in controlled trials with OTC analgesics.
    Diener HC; Pfaffenrath V; Pageler L; Peil H; Aicher B; Lipton RB
    Cephalalgia; 2009 Feb; 29(2):188-93. PubMed ID: 18823361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Review of clinical trials using early acute intervention with oral triptans for migraine management.
    Dowson AJ; Mathew NT; Pascual J
    Int J Clin Pract; 2006 Jun; 60(6):698-706. PubMed ID: 16805756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Economic analysis of triptan therapy for acute migraine: a Medicaid perspective.
    Mullins CD; Subedi PR; Healey PJ; Sanchez RJ
    Pharmacotherapy; 2007 Aug; 27(8):1092-101. PubMed ID: 17655509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Office Treatment of Migraine in 2004].
    Göbel H; Heinze A
    MMW Fortschr Med; 2004 May; 146 Spec No 2():31-2, 34, 36 passim. PubMed ID: 15376699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The 'Act when Mild' (AwM) study: a step forward in our understanding of early treatment in acute migraine.
    Goadsby PJ
    Cephalalgia; 2008 Sep; 28 Suppl 2():36-41. PubMed ID: 18715331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sumatriptan nasal spray in the acute treatment of migraine in adolescents and children.
    Callenbach PM; Pels LP; Mulder PG; Linssen WH; Gooskens RH; van der Zwan JL; Brouwer OF;
    Eur J Paediatr Neurol; 2007 Nov; 11(6):325-30. PubMed ID: 17428708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A group sequential adaptive treatment assignment design for proof of concept and dose selection in headache trials.
    Hall DB; Meier U; Diener HC
    Contemp Clin Trials; 2005 Jun; 26(3):349-64. PubMed ID: 15911469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Symptomatic treatment of migraine with zolmitriptan: experience with 82 patients].
    Pascual J; Navarro A; Caminero AB; Jurado C; Díaz-Insa S; Huerta M
    Neurologia; 2006 May; 21(4):188-91. PubMed ID: 16832773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early treatment in migraine: how strong is the current evidence?
    Gendolla A
    Cephalalgia; 2008 Sep; 28 Suppl 2():28-35. PubMed ID: 18715330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of tonabersat, a gap-junction modulator, in the acute treatment of migraine: a double-blind, parallel-group, randomized study.
    Dahlöf CG; Hauge AW; Olesen J
    Cephalalgia; 2009 Nov; 29 Suppl 2():7-16. PubMed ID: 19723121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of carisbamate for the treatment of migraine in a randomized, double-blind trial.
    Cady RK; Mathew N; Diener HC; Hu P; Haas M; Novak GP;
    Headache; 2009 Feb; 49(2):216-26. PubMed ID: 19222595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rizatriptan does not change cerebral blood flow velocity during migraine attacks.
    Gori S; Morelli N; Bellini G; Bonanni E; Manca L; Orlandi G; Iudice A; Murri L
    Brain Res Bull; 2005 Apr; 65(4):297-300. PubMed ID: 15811594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of botulinum toxin type A for the prophylaxis of episodic migraine headaches: a meta-analysis of randomized, double-blind, placebo-controlled trials.
    Shuhendler AJ; Lee S; Siu M; Ondovcik S; Lam K; Alabdullatif A; Zhang X; Machado M; Einarson TR
    Pharmacotherapy; 2009 Jul; 29(7):784-91. PubMed ID: 19558252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A review of evidence-based medicine and meta-analytic reviews in migraine.
    Tfelt-Hansen P
    Cephalalgia; 2006 Nov; 26(11):1265-74. PubMed ID: 17059433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Therapy of acute migraine attacks and prevention of migraine].
    Diener HC; Limmroth V
    Dtsch Med Wochenschr; 1998 Nov; 123(48):1449-53. PubMed ID: 9858953
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.